人福医药：第十一届董事会第二次会议决议公告

Group 1 - The core point of the article is that Renfu Pharmaceutical announced the approval of its 2025 semi-annual report and several other proposals during the second meeting of its 11th board of directors [2] Group 2 - The announcement was made on the evening of August 27 [2] - The meeting involved the review and approval of the full text and summary of the company's semi-annual report for 2025 [2]